Sviripa Vitaliy M, Kril Liliia M, Zhang Wen, Xie Yanqi, Wyrebek Przemyslaw, Ponomareva Larissa, Liu Xifu, Yuan Yaxia, Zhan Chang-Guo, Watt David S, Liu Chunming
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596.
Center for Pharmaceutical Research and Innovation, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596.
Medchemcomm. 2018;9(1):87-99. doi: 10.1039/C7MD00393E. Epub 2017 Nov 3.
Fluorinated, phenylethynyl-substituted heterocycles that possessed either an -methylamino or -dimethylamino group attached to heterocycles including pyridines, indoles, 1-indazoles, quinolines, and isoquinolines inhibited the proliferation of LS174T colon cancer cells in which the inhibition of cyclin D1 and induction of the cyclin-dependent kinase inhibitor-1 (., p21) served as a readout for antineoplastic activity at a cellular level. On a molecular level, these agents, particularly 4-((2,6-difluorophenyl)ethynyl)--methylisoquinolin-1-amine and 4-((2,6-difluorophenyl)ethynyl)-,-dimethylisoquinolin-1-amine, bound and inhibited the catalytic subunit of methionine S-adenosyltransferase-2 (MAT2A).
带有连接在包括吡啶、吲哚、1-吲唑、喹啉和异喹啉在内的杂环上的甲氨基或二甲氨基的氟化、苯乙炔基取代的杂环化合物抑制了LS174T结肠癌细胞的增殖,其中细胞周期蛋白D1的抑制和细胞周期蛋白依赖性激酶抑制剂-1(即p21)的诱导作为细胞水平抗肿瘤活性的读数。在分子水平上,这些试剂,特别是4-((2,6-二氟苯基)乙炔基)-1-甲基异喹啉-1-胺和4-((2,6-二氟苯基)乙炔基)-1,1-二甲基异喹啉-1-胺,结合并抑制了甲硫氨酸S-腺苷转移酶-2(MAT2A)的催化亚基。